• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Geron Corporation (GERN)

    -NasdaqGS
    3.26 Down 0.01(0.31%) Dec 19, 4:00PM EST
    |After Hours : 3.26 0.00 (0.00%) Dec 19, 7:53PM EST
    Add to Portfolio
    Prev Close:3.27
    Open:3.26
    Bid:N/A
    Ask:4.00 x 200
    1y Target Est:4.63
    Beta:2.91
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:3.19 - 3.32
    52wk Range:1.31 - 5.60
    Volume:8,868,167
    Avg Vol (3m):4,679,030
    Market Cap:512.51M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNDown 0.31%512.51M
    BMYUp 0.84%101.68B
    GSKUp 0.14%104.21B
    NVSUp 0.04%228.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):428.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.12
    Quarterly EPS Est (Dec-14) :0.05
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-5.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback